文献速递脑血管病

经颈动脉血运重建治疗症状性颈内动脉疾病:系统综述与研究的荟萃分析

Transcarotid Arterial Revascularization of Symptomatic Internal Carotid Artery Disease: A Systematic Review and Study-Level Meta-Analysis.
PubMed 文献 · Stroke · 2024-02-01

该系统综述与荟萃分析纳入2000年1月至2023年2月间7项研究共24246例患者,比较经颈动脉血运重建(TCAR)与颈动脉内膜切除术(CEA)及颈动脉支架置入术(CAS)在症状性颈内动脉疾病中的安全性与有效性。结果显示,与CAS相比,TCAR的卒中或短暂性脑缺血发作及心肌梗死发生率相似,但死亡率更低;与CEA相比,TCAR的卒中或短暂性脑缺血发作发生率更高,而心肌梗死和死亡率相似。作者认为TCAR可能较CAS具有一定优势,但需前瞻性随机试验比较三种方式。

要点

  • 与CAS相比,TCAR的卒中或短暂性脑缺血发作(OR 0.77,95%CI 0.33-1.82)及心肌梗死(OR 1.29,95%CI 0.83-2.01)发生率相似,死亡率更低(OR 0.42,95%CI 0.22-0.81)。
  • 与CEA相比,TCAR的卒中或短暂性脑缺血发作发生率更高(OR 1.26,95%CI 1.03-1.54),心肌梗死(OR 0.9,95%CI 0.64-1.38)和死亡率(OR 1.35,95%CI 0.87-2.10)相似。
  • 作者认为TCAR可能较CAS具有一定优势,但需前瞻性随机试验比较三种方式。

核心结论

  • 尽管CEA传统上被认为优于支架置入治疗症状性颈动脉狭窄,但TCAR可能较CAS具有一定优势,需前瞻性随机试验比较三种方式。

研究设计与样本

  • 系统综述与研究的荟萃分析,检索2000年1月至2023年2月间使用TCAR治疗症状性颈内动脉疾病的研究,共纳入7项研究24246例患者,其中TCAR 4771例、CEA 12350例、CAS 7125例;主要结局为30天卒中或短暂性脑缺血发作、心肌梗死和死亡,次要结局为颅神经损伤和大出血;计算汇总OR比较TCAR与CEA及CAS,并按年龄和狭窄程度进行亚组分析,另通过排除血管质量倡议登记人群进行敏感性分析。

主要发现

  • 与CAS相比,TCAR的卒中或短暂性脑缺血发作发生率相似(OR 0.77,95%CI 0.33-1.82),心肌梗死发生率相似(OR 1.29,95%CI 0.83-2.01),死亡率更低(OR 0.42,95%CI 0.22-0.81)。
  • 与CEA相比,TCAR的卒中或短暂性脑缺血发作发生率更高(OR 1.26,95%CI 1.03-1.54),心肌梗死发生率相似(OR 0.9,95%CI 0.64-1.38),死亡率相似(OR 1.35,95%CI 0.87-2.10)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要前瞻性随机试验比较TCAR、CEA和CAS三种方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transcarotid artery revascularization (TCAR) is an interventional therapy for symptomatic internal carotid artery disease. Currently, the utilization of TCAR is contentious due to limited evidence. In this study, we evaluate the safety and efficacy of TCAR in patients with symptomatic internal carotid artery disease compared with carotid endarterectomy (CEA) and carotid artery stenting (CAS). METHODS: A systematic review was conducted, spanning from January 2000 to February 2023, encompassing studies that used TCAR for the treatment of symptomatic internal carotid artery disease. The primary outcomes included a 30-day stroke or transient ischemic attack, myocardial infarction, and mortality. Secondary outcomes comprised cranial nerve injury and major bleeding. Pooled odds ratios (ORs) for each outcome were calculated to compare TCAR with CEA and CAS. Furthermore, subgroup analyses were performed based on age and degree of stenosis. In addition, a sensitivity analysis was conducted by excluding the vascular quality initiative registry population. RESULTS: A total of 7 studies involving 24 246 patients were analyzed. Within this patient cohort, 4771 individuals underwent TCAR, 12 350 underwent CEA, and 7125 patients underwent CAS. Compared with CAS, TCAR was associated with a similar rate of stroke or transient ischemic attack (OR, 0.77 [95% CI, 0.33-1.82]) and myocardial infarction (OR, 1.29 [95% CI, 0.83-2.01]) but lower mortality (OR, 0.42 [95% CI, 0.22-0.81]). Compared with CEA, TCAR was associated with a higher rate of stroke or transient ischemic attack (OR, 1.26 [95% CI, 1.03-1.54]) but similar rates of myocardial infarction (OR, 0.9 [95% CI, 0.64-1.38]) and mortality (OR, 1.35 [95% CI, 0.87-2.10]). CONCLUSIONS: Although CEA has traditionally been considered superior to stenting for symptomatic carotid stenosis, TCAR may have some advantages over CAS. Prospective randomized trials comparing the 3 modalities are needed.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ghannam M, AlMajali M, Khasiyev F, et al. Transcarotid Arterial Revascularization of Symptomatic Internal Carotid Artery Disease: A Systematic Review and Study-Level Meta-Analysis. Stroke. 2024. PMID: 38299350. doi:10.1161/STROKEAHA.123.044246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。